SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks...

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bucky Katt who wrote (5958)12/13/2002 9:36:47 AM
From: xcr600  Read Replies (1) of 48461
 
07:09 ET Siga Tech could become key player in biowarfare defense -- B-Week (SIGA) 1.65: Business Week reports that stk's recent rise from $1.00 reflects the role of Siga in developing a smallpox antiviral drug. Co's research has captured the interest of the U.S. military, which has granted $1.6 mln to Siga to develop a smallpox drug, say sources close to the situation. According to article, Siga's animal testing will begin early next year, and a drug could be approved in two yrs. A Global Partners analyst rates the stock Speculative Buy and has a 12-month price target of $4 to $5.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext